<DOC>
	<DOCNO>NCT02046629</DOCNO>
	<brief_summary>Primary Objective : To assess pharmacokinetic ( PK ) parameter teriflunomide single oral dose 14 mg administration Chinese healthy subject Secondary Objective : To assess safety tolerability single oral dose 14 mg teriflunomide Chinese healthy subject</brief_summary>
	<brief_title>A Study Evaluate Pharmacokinetic Profiles Single 14 mg Teriflunomide Tablet Healthy Chinese Volunteers</brief_title>
	<detailed_description>- Screening : 2 21 day inclusion ( Day -21 Day -2 ) - Institutionalization period : 6 day include 1 treatment day ( Day -1 Day 6 , treatment Day 1 ) - Follow-up : 7-10 day ( may extend ) - End study : Day 38 Day 41 ( may extend ) - Total study duration : maximum 9 week</detailed_description>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Cholestyramine Resin</mesh_term>
	<criteria>Inclusion criterion : Male female subject , 18 45 year age , inclusive . Body weight 50.0 95.0 kg , inclusive , male , 45.0 85.0 kg , inclusive , female , body mass index 19.0 24.0 kg/m2 , inclusive . Certified healthy comprehensive clinical assessment lab test . Subject must use appropriate contraception method . Having give write informed consent prior procedure relate study . Exclusion criterion : Blood donation , volume , within 3 month inclusion . Symptomatic postural hypotension , whatever decrease blood pressure , asymptomatic postural hypotension define decrease systolic blood pressure ≥20 mmHg within 3 minute change supine stand position . Excessive consumption beverage xanthine base ( &gt; 4 cup glass per day ) . If female , pregnancy ( define positive βhCG blood test ) , breastfeed . Any medication ( include St John 's Wort traditional Chinese herb medicine ) within 14 day inclusion within 5 time elimination halflife pharmacodynamic halflife drug , exception hormonal contraception menopausal hormone replacement therapy ; vaccination within last 28 day . Any consumption citrus ( grapefruit , orange , etc ) juice within 5 day inclusion . Subject ( male female ) disagree use appropriate contraception method . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>